ZBP1 and plasma cell myeloma: In contrast, in multiple myeloma, ZBP1 activates IRF3 that, together with IRF4, promotes expression of cell cycle genes and thereby facilitates proliferation of malignant cells (Ponnusamy et al., 2022).